Sabaa International Company for Pharmaceutical and Chemical Industry Past Earnings Performance
Past criteria checks 4/6
Sabaa International Company for Pharmaceutical and Chemical Industry's earnings have been declining at an average annual rate of -18%, while the Pharmaceuticals industry saw earnings growing at 3.1% annually. Revenues have been declining at an average rate of 21.9% per year. Sabaa International Company for Pharmaceutical and Chemical Industry's return on equity is 0.1%, and it has net margins of 0.8%.
Key information
-18.0%
Earnings growth rate
-14.7%
EPS growth rate
Pharmaceuticals Industry Growth | 9.8% |
Revenue growth rate | -21.9% |
Return on equity | 0.1% |
Net Margin | 0.8% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Sabaa International Company for Pharmaceutical and Chemical Industry makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 13 | 0 | 6 | 0 |
30 Sep 23 | 13 | -4 | 6 | 0 |
31 Dec 22 | 18 | 0 | 6 | 0 |
30 Sep 22 | 20 | 2 | 7 | 0 |
30 Jun 22 | 25 | 5 | 7 | 0 |
31 Mar 22 | 37 | 4 | 8 | 0 |
31 Dec 21 | 45 | 5 | 10 | 0 |
30 Sep 21 | 61 | 10 | 12 | 0 |
30 Jun 21 | 66 | 12 | 14 | 0 |
31 Mar 21 | 60 | 11 | 18 | 0 |
31 Dec 20 | 70 | 12 | 20 | 0 |
30 Sep 20 | 70 | 13 | 18 | 0 |
30 Jun 20 | 66 | 9 | 19 | 0 |
31 Mar 20 | 71 | 11 | 17 | 0 |
31 Dec 19 | 67 | 9 | 18 | 0 |
30 Sep 19 | 56 | 2 | 18 | 0 |
30 Jun 19 | 56 | 2 | 18 | 0 |
31 Mar 19 | 53 | 2 | 18 | 0 |
31 Dec 18 | 50 | 2 | 16 | 0 |
30 Sep 18 | 56 | 11 | 14 | 0 |
30 Jun 18 | 87 | 15 | 11 | 0 |
31 Mar 18 | 86 | 17 | 8 | 0 |
31 Dec 17 | 84 | 17 | 7 | 0 |
30 Sep 17 | 96 | 11 | 7 | 0 |
30 Jun 17 | 58 | 7 | 7 | 0 |
31 Mar 17 | 52 | 5 | 7 | 0 |
31 Dec 16 | 46 | 5 | 6 | 0 |
30 Sep 16 | 22 | 2 | 6 | 0 |
30 Jun 16 | 20 | 2 | 6 | 0 |
31 Mar 16 | 20 | 3 | 6 | 0 |
31 Dec 15 | 19 | 2 | 6 | 0 |
30 Sep 15 | 17 | 2 | 5 | 0 |
30 Jun 15 | 18 | 3 | 5 | 0 |
31 Mar 15 | 16 | 2 | 6 | 0 |
31 Dec 14 | 15 | 2 | 5 | 0 |
30 Sep 14 | 16 | 2 | 6 | 0 |
30 Jun 14 | 16 | 3 | 6 | 0 |
31 Mar 14 | 15 | 3 | 5 | 0 |
31 Dec 13 | 15 | 3 | 6 | 0 |
Quality Earnings: SIPC has high quality earnings.
Growing Profit Margin: SIPC's current net profit margins (0.8%) are higher than last year (0.08%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SIPC's earnings have declined by 18% per year over the past 5 years.
Accelerating Growth: SIPC's earnings growth over the past year (670.6%) exceeds its 5-year average (-18% per year).
Earnings vs Industry: SIPC earnings growth over the past year (670.6%) exceeded the Pharmaceuticals industry 27.9%.
Return on Equity
High ROE: SIPC's Return on Equity (0.1%) is considered low.